Get started
Author

Chinping Chng

ORCID: 0000-0002-1959-9311
Observed ORCID: 0000-0002-1959-9311
OpenAlex ID: A5049252868
A key developmental regulator controls the synthesis of the antibiotic erythromycin in Saccharopolyspora erythraea
2008 · Chinping Chng, Amy M. Lum, et al. · Proceedings of the National Academy of Sciences · 87
An engineered T7 RNA polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis
2024 · Mathew Miller, Oscar Alvizo, et al. · Faraday Discussions · 44
PDF
Optimizing human α-galactosidase for treatment of Fabry disease
2023 · William C. Hallows, Kristen Skvorak, et al. · Scientific Reports · 20
PDF
Oral enzyme therapy for maple syrup urine disease ( MSUD ) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primates
2023 · Kristen Skvorak, Joyce Liu, et al. · Journal of Inherited Metabolic Disease · 4
PDF
Development of a Potent Engineered Microbial Lipase for the Treatment of Exocrine Pancreatic Insufficiency
2026 · Christos S. Karamitros, Chinping Chng, et al. · Gastro Hep Advances · 1
Engineering α-glucosidase to improve protein stability and cellular uptake for the potential treatment of Pompe disease
2021 · Rachel C. Botham, William C. Hallows, et al. · Molecular Genetics and Metabolism · 1
An engineered β-galactosidase with improved stability and cross-correction for the potential treatment of GM1 Gangliosidosis via AAV gene therapy
2023 · Charu Reddy, Ouma Onguka, et al. · Molecular Genetics and Metabolism
modeling of GM1 gangliosidosis using iPSC-derived cellular and organoid CNS models
2023 · Christopher E. Schmitt, Grace S. Lee, et al. · Molecular Genetics and Metabolism
Engineering α-galactosidase A (GLA) to improve protein stability, efficacy and reduced immune response for the treatment of Fabry disease
2020 · William Casey Hallows, Kristen Skvorak, et al. · Molecular Genetics and Metabolism
Works count: 9
Citation count: 157
H-index: 4
I10-index: 3
Year
Topic
Type